A new paper by Jonah Sacha, Ph.D., and colleagues at OHSU's Vaccine & Gene Therapy Institute and Oregon National Primate Research Center shows that Mauratian macaques can be used as model organisms to explore stem cell transplants as a means to treat and potentially cure HIV. (OHSU/Kristyna Wentz-Graff) 

A new paper by Jonah Sacha, Ph.D., and colleagues at OHSU's Vaccine & Gene Therapy Institute and Oregon National Primate Research Center shows that Mauratian macaques can be used as model organisms to explore stem cell transplants as a means to treat and potentially cure HIV. (OHSU/Kristyna Wentz-Graff) 

Research associate Jason Reed performs cell culture maintenance in the Sacha lab, at the OHSU Vaccine and Gene Therapy Institute, November 3, 2017. (OHSU/Kristyna Wentz-Graff) 

Jonah Sacha, Ph.D., at OHSU's Vaccine & Gene Therapy Institute and Oregon National Primate Research Center. (OHSU/Kristyna Wentz-Graff) 

A new paper by Jonah Sacha, Ph.D., and colleagues at OHSU's Vaccine & Gene Therapy Institute and Oregon National Primate Research Center shows that Mauratian macaques can be used as model organisms to explore stem cell transplants as a means to treat and potentially cure HIV. (OHSU/Kristyna Wentz-Graff) 

OHSU School of Medicine Dean Sharon Anderson, a nephrologist, has cared for patients like Richard Waliser at the VA Portland Health Care System since coming to OHSU 26 years ago – and she continues to do so, even as dean. “She’s very practical, easy to talk with,” said Waliser, who has survived on dialysis for 28 years. “She makes you feel like when you’re talking, you have something to say.” (OHSU/Erin Hoover Barnett)

Michael Heinrich, M.D. meets with Victoria Castle of Sacramento, California during an appointment, November 1, 2017 at OHSU. Castle, who was diagnosed with gastrointestinal stromal tumor in 2009, began seeing Heinrich in 2014. (OHSU/Kristyna Wentz-Graff)

Michael Heinrich, M.D., professor in the division of hematology and medical oncology at the OHSU Knight Cancer Institute; physician at the Portland Veterans Affairs Medical Center, November 1, 2017. (OHSU/Kristyna Wentz-Graff)

Michael Heinrich, M.D., works with patients diagnosed with gastrointestinal stromal tumors (GIST). (OHSU/Kristyna Wentz-Graff)

Michael Heinrich, M.D., meets with Todd Bramhall during an exam, November 1, 2017. Bramhall is one of 3,000-6,000 people diagnosed annually with a rare stomach cancer called gastrointestinal stromal tumor (GIST). (OHSU/Kristyna Wentz-Graff)